UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D. C. 20549



                Proxy Statement Pursuant to Section 14(a) of the
                        Securities Exchange Act of 1934



Filed by the Registrant  [X]
Filed by a Party other than the Registrant  [ ]


Check the appropriate box:

[ ] Preliminary Proxy statement
[ ] Confidential, for Use of the Commission Only (as permitted by
     Rule 14a-6(e)(2))
[X] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12


                              Sonex Research, Inc.
--------------------------------------------------------------------------------
(Name of Registrant as Specified in its Charter)

--------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)


Payment of Filing Fee (Check the appropriate box):

[X] No fee required.
[ ] Fee computed per Exchange Act Rules 14a-6(i)(1) and 0-11.



















                              SONEX RESEARCH, INC.
                                23 Hudson Street
                               Annapolis, MD 21401
                      Tel: 410-266-5556; Fax: 410-266-5653
				    E-mail: info@sonex-na.com
                         Website: www.sonexresearch.com

        

                       2004 ANNUAL MEETING OF SHAREHOLDERS
                      NOTICE OF MEETING AND PROXY STATEMENT



To the Shareholders of Sonex Research, Inc.:

You are  invited to attend the 2004  Annual  Meeting  of  Shareholders  of Sonex
Research,  Inc. (the "Corporation"),  which will be held on Monday, December 20,
2004 at 10:00 a.m.  local time in the Dorsey  Room in the  Hampton Inn & Suites,
located in the ARINC Corporate Park, 124 Womack Drive, Annapolis,  Maryland. The
Board of Directors  has set the close of business on  September  20, 2004 as the
record date for the Annual  Meeting.  This means that owners of the Common Stock
and Preferred  Stock of the  Corporation as of that date are entitled to receive
notice of, and to vote at, the Annual Meeting and any adjournment thereof.

Shareholders  will act upon the following  matters and such other matters as may
properly come before the Annual Meeting or any adjournment thereof:


        PREFERRED STOCK  PROPOSAL:  To elect one individual to serve as a Class
        I Preferred Stock director until the Annual Meeting of Shareholders in
        2005.

        COMMON STOCK  PROPOSAL:  To elect one individual to serve as a Class III
        Common Stock  director of the  Corporation  until the Annual  Meeting of
        Shareholders in 2007.


If you own  shares of  Common  Stock  that are  registered  in your name  (i.e.,
represented  by actual stock  certificates),  you are receiving a Proxy directly
from the Corporation.  Holders of shares of Common Stock that are held of record
in an account  with a financial  institution  such as a brokerage or bank (i.e.,
held in "street  name") are  receiving a proxy voting  instructions  form from a
proxy  processing  firm by mail or via the Internet.  Whether or not you plan to
attend the Annual Meeting,  please complete,  date, sign and promptly return the
enclosed Proxy or voting  instructions  form in the  accompanying  envelope,  or
respond  over the  Internet  or by  telephone,  to assure  that your  shares are
represented at the Annual  Meeting.  Proxies  returned with no voting  direction
indicated will be voted "FOR" the proposals.

You may attend the Annual  Meeting and vote in person shares  registered in your
name either by  submitting  a completed  Proxy or by  completing a ballot at the
Annual Meeting. If you have returned a Proxy to the Corporation but later decide
to attend in person,  you may revoke  your Proxy at the Annual  Meeting and cast
your vote in person by ballot.  If you own shares of Common Stock in street name
and you wish to vote in person,  you must mark the  appropriate box on the proxy
voting  instructions form and return it to the proxy processing firm, which will
then  send you a Legal  Proxy to allow  you to vote the  shares by ballot at the
Annual Meeting.


                                 By Order of the Board of Directors


                                 /s/ George E. Ponticas

                                 George E. Ponticas, Secretary
                                 December 3, 2004




                             PROXY SOLICITATION

This Notice of Meeting and Proxy Statement is furnished to shareholders of Sonex
Research,  Inc. (the  "Corporation")  in  connection  with the  solicitation  of
Proxies on behalf of its Board of  Directors  for use at the  Annual  Meeting of
Shareholders of the Corporation to be held on December 20, 2004 for the purposes
set forth on the cover page of this Notice of Meeting and Proxy  Statement.  The
Board of  Directors  has fixed  September  20,  2004 as the record  date for the
determination of shareholders  entitled to notice of, and to vote at, the Annual
Meeting.

If more than one registered  shareholders  are listed at the same address and do
not participate in electronic  delivery,  a single copy of the Annual Report and
Proxy Statement has been sent to this address rather than send multiple packages
in the  interest of reducing  associated  expenses  for  printing  and  postage.
Separate proxy cards for each  shareholder,  however,  have been included.  This
consolidation of mailings is referred to as  "Householding"  and is permitted by
the Securities and Exchange  Commission  (SEC) if you agree to, or do not object
to, the practice.  If you object to the  Householding of your materials,  please
contact the  Corporation by mail or by telephone to request  separate copies for
each shareholder listed at your address for this and future mailings.  For those
who hold shares in street name, such requests must be made per the  instructions
contained on the voting  instructions  form. If you agree to the Householding of
your materials,  no action on your part is required,  and all future mailings to
your address will be Householded until you inform otherwise.

The cost of preparing,  assembling and mailing of proxy  materials will be borne
by the Corporation.  The Corporation will supply proxy materials as requested to
brokerage houses and other custodians, nominees and fiduciaries for transmission
to the beneficial owners of the Corporation's  securities.  The Corporation will
reimburse such brokerage  houses and other  custodians for their  expenses.  The
approximate  mailing  date of this  Notice of  Meeting  and Proxy  Statement  is
December 3, 2004. A list of shareholders as of the record date will be available
for inspection by any shareholder for any purpose relevant to the Annual Meeting
during  regular  business  hours at the office of the  Corporation  for ten days
prior to the Annual Meeting.


                              CLASSES OF SECURITIES

The Corporation has two classes of voting securities:  its $.01 par value common
stock (the "Common  Stock") and its $.01 par value  convertible  preferred stock
(the "Preferred  Stock").  Each share of Common Stock is entitled to one vote on
all  matters as may  properly  come  before the  Annual  Meeting.  Each share of
Preferred Stock is convertible at any time at the option of the holder into that
number of shares of Common Stock  determined by dividing the number of shares of
Preferred  Stock by 0.35. The Preferred  Stock has priority in liquidation  over
the Common Stock, but it carries no stated dividend.  Additionally,  the holders
of Preferred  Stock,  voting as a separate  class,  have the right to elect that
number of directors of the Corporation  which represents a majority of the total
number of  directors.  The only other  matters with respect to which  holders of
Preferred  Stock are entitled to vote  concern a  consolidation,  merger,  share
exchange or transfer of assets. Each share of Preferred Stock is entitled to one
vote on the Preferred Stock Proposal.

The  Corporation  is presently  authorized to issue up to  48,000,000  shares of
Common Stock and 2,000,000  shares of Preferred  Stock. At the close of business
on September 20, 2004,  there were 27,112,669  shares of Common Stock issued and
outstanding  held by  approximately  900  registered  holders,  with  shares for
approximately  1,735 additional  beneficial  owners being held in street name by
brokers,  dealers,  banks, and other entities, and 1,540,001 shares of Preferred
Stock issued and outstanding held by seven registered holders.


                                     VOTING

A quorum is required  in order for the  Corporation  to conduct  business at the
Annual Meeting.  The presence,  in person or by Proxy, of the majority in number
of the  outstanding  shares of Common Stock and Preferred Stock as of the record
date  constitutes  a quorum.  If a quorum is  attained  at the  Annual  Meeting,
directors  will be elected by a plurality of the shares  present and entitled to
vote.  Shares  represented  by a  properly  completed  Proxy  will be counted as
present at the Annual  Meeting for  purposes of  determining  a quorum,  without
regard to  whether  the Proxy  indicates  that the  shareholder  is  casting  or
withholding a vote.  Unless otherwise  directed by the  shareholder,  the shares
represented by executed  Proxies returned to the Corporation will be voted "FOR"
the election of  directors,  and in the  discretion  of the Proxy  holders as to
other matters coming before the Annual Meeting.

A Proxy may be revoked at any time before it is voted by giving  written  notice
of  revocation,  or by  delivery of a later dated  Proxy,  to the  Corporation's
Secretary  prior to the  Annual  Meeting.  A Proxy  may also be  revoked  if the
shareholder  is present at the Annual  Meeting and gives  written  notice to the
Corporation's Secretary of his revocation at such time.


                               BOARD OF DIRECTORS

The Corporation's Board of Directors is divided into two categories: (1) "Common
Stock"  directors  elected by the holders of Common  Stock;  and (2)  "Preferred
Stock"  directors  elected by the holders of  Preferred  Stock.  Pursuant to the
Corporation's  Charter, the holders of the Preferred Stock, voting as a separate
class, have the right to elect that number of directors of the Corporation which
represents a majority of the total number of directors.  These two categories of
directors  are further  divided into three  classes as nearly equal in number as
possible,  with the term of one of the three  classes of  directors  expiring at
each annual meeting of shareholders.  The members of each class of directors are
to hold office for terms of three years until their successors have been elected
and  qualified.  The  terms of Class I,  Class II and Class  III  directors  are
scheduled to expire at the annual  meetings of  shareholders to be held in 2005,
2006 and 2004, respectively.

During  2003 the Board of  Directors  held two  meetings.  All of the  directors
attended  at least 75% of the  total  number of  regularly  scheduled  meetings.
Shareholders may communicate with the Board of Directors,  a specific  director,
or the  non-management  or independent  directors as a group by sending  written
communications  to the attention of the  Corporate  Secretary,  Sonex  Research,
Inc.,  23  Hudson  Street,   Annapolis,   Maryland,   21401,   by  facsimile  to
410-266-5653, or by email to george.ponticas@sonex-na.com.

The Corporation's By-laws state that the Board of Directors shall consist of not
fewer than three directors,  with the total number of directors to be set by the
Board by  resolution.  In July 1997 the total number of  directors  was fixed at
five,  and, from  December 2001 through March 2003 the Board  consisted of three
Preferred Stock directors and two Common Stock directors. In March 2003 Mr. John
H. Drewanz,  a Class II Common Stock director since October 2001 and Chairman of
the  Corporation's  Board of Directors  since  October  2002,  resigned from the
Board. The Board of Directors  subsequently  decided against filling the vacancy
or naming a new Chairman.  In July 2003 the Board of Directors  acted to fix the
number of directors at four,  consisting of three  Preferred Stock directors and
one Common Stock director.

In late January and early February 2004, the three  Preferred  Stock  directors,
Mr.  Lawrence H. Hyde, Mr. Charles C.  McGettigan,  and Mr. Myron A. Wick,  III,
resigned from the Board,  citing other business  responsibilities  as the reason
for resignation.  The only continuing  member of the Board was the Corporation's
Chief  Executive  Officer,  Dr.  Andrew A.  Pouring,  a Class III  Common  Stock
director. In connection with the resignations, the total number of directors was
fixed at three, consisting of two Preferred Stock directors and one Common Stock
director.  Named to the Board on an interim basis were the  Corporation's  Chief
Financial Officer, Mr. George E. Ponticas, to serve as a Class I Preferred Stock
director,  and one  independent  director,  Mr. Herbert J.  Mitschele,  Jr., the
beneficial owner of approximately 5% of the Corporation's Common Stock, to serve
as a Class II Preferred Stock director.

In late February 2004 the Corporation's reconstituted Board of Directors hired a
new president, Mr. Roger D. Posey, to fill the position that had been vacant. In
March  2004 Mr.  Ponticas  resigned  from the Board  and Mr.  Posey was named to
replace him as a Class I Preferred Stock director.  In April 2004 Mr.  Mitschele
resigned from the Board and Mr. Jim Z.I.  Williams was named to replace him as a
Class II Preferred Stock  director.  In July 2004 Dr. Pouring was named Chairman
of the Board and Mr. Posey was named Chief  Executive  Officer.  In October 2004
Mr. Posey resigned as President and Chief Executive  Officer and was replaced by
Dr.  Pouring.  In November 2004 Mr. Posey resigned from the Board.  Mr. Ponticas
was  named to  replace  him on an  interim  basis as a Class I  Preferred  Stock
director.  Later in November  2004,  Mr.  Williams also resigned from the Board,
thereby  creating a vacancy.  The Board has not had the  opportunity to fill the
vacancy as of the date of preparation of this Proxy  Statement.  The Corporation
will seek to add  qualified  individuals  to its Board of Directors  who have no
current  affiliation  with the Corporation in order to constitute a Board with a
majority of independent directors.

Due to the small total  number of  directors,  the Board does not have  separate
Nominating,  Compensation or Audit Committees;  however,  the functions of these
committees have been performed by the Board as a whole. The Corporation does not
have an Audit  Committee  charter.  The Board  believed  that its prior  outside
directors  possessed  the necessary  independence  and skills to perform all the
functions  normally  assigned  to  separate  Nominating,  Compensation  or Audit
Committees.

Based on their education and business experience,  former outside directors Hyde
and  McGettigan,  both of whom  have  experience  overseeing  or  assessing  the
performance of companies or public  accountants with respect to the preparation,
auditing  or  evaluation  of  financial  statements,  were  designated  as audit
committee  "financial  experts" with respect to Audit  Committee  functions that
were  performed  by the  Board  as a  whole.  In  general,  an  audit  committee
"financial  expert" means an individual  who possesses (i) an  understanding  of
generally  accepted  accounting  principles and financial  statements;  (ii) the
ability to assess the general  application of such principles in connection with
the accounting for estimates, accruals and reserves; (iii) experience preparing,
auditing,  analyzing or evaluating financial  statements  containing the breadth
and level of complexity of  accounting  issues that are generally  comparable to
such issues  encountered by the small business  issuer's  financial  statements;
(iv)  an  understanding  of  internal  controls  and  procedures  for  financial
reporting; and (v) an understanding of audit committee functions.

The Board  currently  does not have any outside  directors  designated  as audit
committee "financial experts". In performing the duties typically assigned to an
audit  committee,  the entire Board (1) reviewed and  discussed the 2003 audited
financial statements of the Corporation with management;  (2) discussed with the
independent   accountants  of  the  Corporation  the  independent   accountants'
judgments about the quality,  not just the  acceptability,  of the Corporation's
accounting  principles,  including the clarity and completeness of the financial
statements and related note disclosures; (3) received written assurance from the
independent  accountants with respect to independence;  and (4) recommended that
the 2003  audited  financial  statements  be included in the  December  31, 2003
Annual Report on Form 10-KSB for filing with the SEC.

While it is the function of the Board to recommend  potential nominees for Board
positions,  it is also the policy of the Board to consider nominees  recommended
by security holders. Such recommendations should be addressed to the Chairman of
the Board,  at the address of the  Corporation,  and should include the name and
address of the security holder  submitting the nomination and a detailed listing
of the business  experience and particular  qualifications  of the nominee.  The
Board will review the  nomination at its next meeting  following  receipt of the
nomination  and respond  accordingly  to the security  holder who  submitted the
nomination.


                        PRINCIPAL SECURITY SHAREHOLDERS

The following table sets forth as of September 20, 2004 information  relating to
beneficial  ownership of Common Stock by directors and executive officers of the
Corporation,  individually  and as a group,  and any other  persons known by the
Corporation  to be the  beneficial  owner  of  more  than  five  percent  of the
currently issued and outstanding  Common Stock. A reporting person is considered
the  "beneficial  owner" of a security if that person has or shares the power to
vote or to direct  the  voting of such  security,  or the power to dispose or to
direct the disposition of such security.  Under this  definition,  more than one
person  may be a  beneficial  owner of  securities  as to which he has no record
ownership  interest,  and the same shares may be beneficially owned by more than
one reporting person.

Beneficial  ownership includes securities which the reporting person owns or has
the right to  acquire  or the  obligation  to  dispose  within 60 days,  such as
through  the  exercise  of  options,  warrants,  puts and calls,  or through the
conversion of Preferred  Stock.  The  percentage  of beneficial  ownership for a
reporting  person assumes that the person has exercised all options and warrants
and converted all  convertible  securities  which are exercisable or convertible
within 60 days, and is based on the number of outstanding shares of Common Stock
of the Corporation plus the number of such shares which the reporting person has
the right to acquire within 60 days, and assumes no other persons  exercised any
options or warrants or converted  any of their  convertible  securities.  Unless
otherwise  noted,  all  shares  are  beneficially  owned  and  sole  voting  and
investment power is held by the persons named.


                           Total Beneficial Ownership
                           --------------------------

                              Common     Rights to    Total shares
                              shares      acquire     beneficially     Percent
 Name and address (1)         owned       shares (2)     owned        of class
 --------------------       ---------   ---------      ---------      --------

George E. Ponticas            626,262     643,928      1,270,190         4.6
Roger D. Posey (5)            600,000     200,000        800,000         2.9
Andrew A. Pouring           1,053,239     433,928      1,487,167         5.4
Jim Z.I. Williams (5)                      25,000         25,000         0.1

All directors and officers
 as a group (4 persons)     2,279,501   1,302,856      3,582,357        12.6

Proactive, et.al. (3)       1,926,564   2,928,570      4,855,134  (4)   16.2
  San Francisco, CA

Charles C. McGettigan (6)   1,301,618   1,839,285      3,140,903  (4)   10.8
  San Francisco, CA

Myron A. Wick, III (6)      1,301,618   1,839,285      3,140,903  (4)   10.8
  San Francisco, CA

Lawrence H. Hyde (7)          644,986   1,839,286      2,484,272         9.0
  Harwich Port, MA

GECI (8)                    1,450,000     750,000      2,200,000         7.9
  Arnold, MD

Herbert J. Mitschele (9)    1,306,414      90,000      1,396,414         5.1
  Far Hills, NJ


-----------------------------
(1)  The business  address for each  director and named  executive  officer is
     23 Hudson Street,  Annapolis,  Maryland,  21401.
(2)  See detail provided in the following table.
(3)  Includes shares  beneficially owned directly and indirectly by Proactive
     Partners, L.P. and several affiliated entities and individuals ("Proactive,
     et.al."), as originally reported in a Form 13D filing with the SEC.  The
     current  SEC filings for this  investor group are made by reporting persons
     Gruber & McBaine  Capital  Management, LLC (GMCM), a limited liability
     company that is an investment  advisor for client accounts and a general
     partner of investment  limited  partnerships; John D. Gruber and J.
     Patterson  McBaine,  who are  managers,  members and portfolio  managers
     of GMCM;  and Eric B.  Swergold,  who is a member  and portfolio  manager
     of GMCM.  The total  shares  reported  is the number of shares beneficially
     owned in accounts and investment  partnerships in which the reporting
     persons have some  pecuniary  interest;  the total  excludes shares held in
     other client accounts managed by GMCM in which the reporting persons  have
     no  pecuniary  interest.   The  reporting  persons  disclaim beneficial
     ownership of shares with respect to which  indirect  beneficial ownership
     is reported  except to the extent of that reporting  person's pro rata
     pecuniary interest therein.
(4)  Includes 2,765,903 shares  beneficially owned by Proactive,  et.al.,  which
     shares could be deemed to be beneficially  owned by both Mr. McGettigan and
     Mr. Wick by virtue of their executive and ownership positions in Proactive,
     et.al.  Both  individuals  exercise shared voting and investment power with
     respect to such shares.
(5)  Resigned as a director in November 2004.
(6)  Resigned as a director in January 2004.
(7)  Resigned as a director in February 2004.
(8)  The Corporation  entered into a one-year  consulting  agreement in February
     2004 with Global Equity Consultants,  Inc. (GECI) for business development,
     product planning, corporate structure and financial advisory services, with
     payment to be made in the form of  1,750,000  shares of Common  Stock,  and
     ten-year,  immediately  exercisable  warrants to purchase 250,000 shares of
     Common  Stock at $.35 per  share,  250,000  shares at $.55 per  share,  and
     250,000 shares at $.75 per share.
(9)  Served as a director in February and March 2004.



                           Rights to Acquire Shares

                                                                       Total
                                     Exercisable          Preferred  rights to
                         Exercisable   (put)/  Exercisable  stock     acquire
        Name               options    call (2)   warrants converted   shares
--------------------      ---------- ---------- --------- --------- ----------

George E. Ponticas          562,500               80,000      1,428    643,928
Roger D. Posey              200,000                                    200,000
Andrew A. Pouring           340,000               92,500      1,428    433,928
Jim Z.I. Williams            25,000                                     25,000

All directors and officers
 as a group (4 persons)   1,127,500              172,500      2,856  1,302,856

Proactive , et.al.                   (1,214,286)          4,142,856  2,928,570

Charles C. McGettigan (1)   375,000    (607,143)          2,071,428  1,839,285

Myron A. Wick, III (1)      375,000    (607,143)          2,071,428  1,839,285

Lawrence H. Hyde            625,000   1,214,286                      1,839,286

GECI                                             750,000               750,000

Herbert J. Mitschele         25,000               25,000     40,000     90,000

---------------------------

(1)  Includes  1,464,285  shares  beneficially  owned by Proactive,  et.al.,
     which  shares  could be  deemed  to be  beneficially  owned by both Mr.
     McGettigan  and Mr.  Wick by virtue of their  executive  and  ownership
     positions in Proactive,  et.al.  Both individuals exercise shared voting
     and investment power with respect to such shares.
(2)  Represents  ten-year  options granted in December 1997 and December 1999 by
     Proactive,  et.al.  to Mr.  Hyde,  a former  officer  and  director  of the
     Corporation,  to purchase 714,286 shares and 500,000 shares,  respectively,
     of Common Stock presently owned by Proactive,  et.al., at an exercise price
     of $.35 and $.50 per share,  respectively.  The December  1997 and December
     1999 options became  exercisable at the rate of 20% and 25%,  respectively,
     per year beginning with the date of grant.  Because these agreements relate
     to shares which are already  outstanding,  the exercise of such rights will
     not  result  in an  increase  in the  total  number  of  the  Corporation's
     outstanding  shares for purposes of computing the  percentage of beneficial
     ownership of each reporting  person.  Mr.  McGettigan and Mr. Wick each has
     indirect  beneficial  ownership  in 50%  of the  shares  subject  to  these
     agreements.



                                STOCK OPTION PLAN

The Corporation maintains a non-qualified stock option plan adopted in 1987 (the
"Plan") which has made  available for issuance a total of 7.5 million  shares of
Common  Stock.  The  Corporation  does not have any other stock  option or other
similar equity compensatory plans. Shareholder approval was not required for the
adoption of the Plan,  nor is it required for any  amendments  to the Plan.  All
directors,  full-time  employees and consultants to the Corporation are eligible
for  participation.  Option awards are determined at the discretion of the Board
of  Directors.  Upon a change in control  of the  Corporation,  all  outstanding
options granted to employees,  officers and directors become vested with respect
to those options which have not already vested.  Options  outstanding  expire at
various dates through April 2014. A copy of the Plan has been filed with the SEC
and is incorporated by reference to the Corporation's Registration Statement No.
33-34520 on Form S-8.

Pertinent  information as of September 20, 2004 regarding shares of Common Stock
issuable  pursuant to options  granted or  available  for future grant under the
Plan is as follows:

    Shares issuable upon exercise of outstanding options       4,733,907
    Weighted average exercise price per share                      $0.40
    Shares available for future issuance                       1,330,425


                       COMPENSATION OF EXECUTIVE OFFICERS

The following table sets forth the  compensation  paid by the Corporation to its
chief  executive  officer  and any other  executive  officer  who earned  annual
compensation  during  the most  recently  completed  year in excess of  $100,000
(together referred to as the "Named Executives").


                           Summary Compensation Table


                               Annual compensation
                        ---------------------------------------
                                      Salary                       Long-term
                              ----------------------    Accrued   compensation
Name and Position       Year   Current      Deferred     bonus    # of options
-----------------       ----  --------      --------   --------   ------------

Dr. Andrew A. Pouring   2003  $ 87,500 (1)  $ 37,500   $ 25,000     100,000
 CEO & Chief Scientist  2002    87,500 (1)    37,500          0     100,000 (3)
                        2001    87,500 (1)    37,500     10,000      35,000

Mr. George E. Ponticas  2003  $ 90,000      $ 30,000   $ 25,000      50,000
 CFO & Secretary        2002    86,400 (2)     9,600     25,000     200,000
                        2001    86,400 (2)     9,600     25,000     100,000


     (1) Includes $76,567 for 2003, $79,933 for 2002 and $33,657 for 2001
         which has not been paid as of December 31, 2003
     (2) Includes  $53,171  for 2002 and  $33,232  for 2001 which has not been
         paid as of December 31, 200
     (3) In November 2002 Dr. Pouring was granted an option to purchase 100,000
         shares of Common Stock effective as of January 1, 2003.


In order to help conserve the Corporation's limited cash resources, however, the
Named Executives for several years have voluntarily  deferred receipt of payment
of significant  portions of their authorized annual salaries upon request by the
Board of Directors. By written agreement with the Corporation, these individuals
and other current and former  employees  consented to the deferral of payment of
amounts so accumulated  until the Corporation has received  licensing revenue of
at least $2 million or at such earlier date as the Board of Directors determines
that the  Corporation's  cash flow is  sufficient  to allow  such  payment.  The
conditions that would require  repayment of deferred  amounts have yet to occur.
(Note:  At the  conclusion  of a legal  challenge by two former  officers of the
Corporation  initiated in 1993 demanding full payment of deferred  salaries upon
the  termination  of their  employment,  in 1996 the  Maryland  Court of Special
Appeals  rejected  this  demand and ruled that the  written  agreement  to defer
compensation was a valid and enforceable contract.) For many years through 1998,
Dr. Pouring had been  deferring 40% of his annual  salary.  In January 1999, the
percentage  deferral  was  reduced to 30%.

For many years through 2002,  Mr.  Ponticas had been deferring 10% of his annual
salary.  The authorized full annual salary for Dr. Pouring has been $125,000 for
the past three years,  while the salary for Mr.  Ponticas was  increased in 2003
from $96,000 to $120,000,  with 25% of the salary being deferred.  As of January
1, 2004, Dr. Pouring is being compensated as a consultant rather than a salaried
employee,  with  related  compensation  not  subject to the terms of the written
agreement  described above for the deferral of payment of current  compensation.
Also as of January 1, 2004, Mr.  Ponticas is no longer  deferring any portion of
his authorized salary. As of December 31, 2003, a total of $486,423 and $155,326
in deferred salary is owed to Dr. Pouring and Mr. Ponticas,  respectively,  that
is payable under the conditions described above.
The  Corporation  operated  under  severe cash flow  difficulties  for  extended
periods during 2001 and 2002,  prompting its two officers to voluntarily  and at
their own discretion  defer receipt of payment of significant  portions of their
current wages to reduce the Corporation's  monthly cash  requirements.  With the
generation  of cash flow from  revenues  earned under  contracts  awarded to the
Corporation  during the second  half of 2002,  some of the  amounts  owed to the
Corporation's  officers  were  repaid in  December  2002.  Also at that time the
Corporation's  officers began  receiving  their current wages.  During the first
quarter of 2003 Dr. Pouring once again began deferring some of his current wages
and, since April 2003, he has deferred  nearly all of his current  compensation.
As of  December  31,  2003,  total such wages  payable  to Dr.  Pouring  and Mr.
Ponticas  were $190,157 and $86,403,  respectively.  During the third quarter of
2004, Mr. Ponticas again was asked to defer much of his current compensation, as
was Mr. Roger D. Posey,  who served as an executive  officer of the  Corporation
from February 2004 to October 2004.  Through September 30, 2004, Dr. Pouring and
Mr.  Ponticas  had not been paid  compensation  for 2004 of $45,195 and $21,922,
respectively.

In December  of each of the past  several  years,  the  Corporation  has awarded
bonuses,  totaling $65,077 in 2003, $37,500 in 2002, and $57,500 in 2001, to its
officers  and  employees,  including  the amounts  reported  above for the Named
Executives.  The bonus awards in each year were made with the  stipulation  that
payment  of such  bonuses  would  be  deferred  until  the  Board  of  Directors
determines that the  Corporation's  cash resources are sufficient to enable such
payments.  In a private  financing in March 2002, Dr.  Pouring and Mr.  Ponticas
accepted  Common  Stock in  payment of accrued  bonuses  of $9,000  each.  As of
December 31, 2003,  $47,500 and $75,000 in accrued bonuses  remained  payable to
Dr. Pouring and Mr. Ponticas, respectively.

The bonus awards and option grants to the Named Executives reflect the fact that
since  2001  these  individuals  have  made   extraordinary   sacrifices,   both
financially  in the amount of wages that have gone unpaid,  and  personally,  to
enable  the  Corporation  to  remain  in  operation  given  its  poor  financial
condition,  and to provide  incentive for the Named  Executives to remain in the
employment of the Corporation under such difficult continuing conditions.

In order to avoid long-term financial commitments,  through 2003 the Corporation
did not execute employment agreements with any of its personnel. The salaries of
executive  officers are set by the Board of Directors on an annual  basis.  With
the exception of the granting of stock options, the Corporation does not pay its
Named  Executives any bonuses or any type of long-term  compensation in the form
of restricted stock awards,  stock  appreciation  rights (SARs) or other form of
long-term incentive plan payments.


                        Option Grants In Last Fiscal Year

                                    Individual Grants
             -------------------------------------------------------------------
             Number of    % of total
            securities      options
            underlying    granted to
              options    employees in    Exercise     Market        Expiration
 Name         granted     fiscal year      price       price           date
 ----         -------     -----------      -----       -----      -------------

Pouring       100,000          45%         $.25        $.13       Dec. 30, 2013

Ponticas       50,000          23%         $.25        $.13       Dec. 30, 2013




               Aggregated Option/SAR Exercises In Last Fiscal Year
                      And Fiscal Year-end Option/SAR Values


                                    Number of securities    Value of unexercised
                                   underlying unexercised       in-the-money
                                      options/SARs at         options/SARs at
                                     December 31, 2003       December 31, 2003
          # of shares								  (1)
          acquired on     Value         Exercisable/            Exercisable/
  Name     exercise     realized       Unexercisable           Unexercisable
--------  -----------   --------   ----------------------   -------------------

Pouring:
  @ $.25       0           $0         185,000 / 150,000            $0/$0
  @ $.50       0           $0         105,000 / 0                  $0/$0
  @ $.75       0           $0          25,000 / 0                  $0/$0

Ponticas:
  @ $.25       0           $0         342,500 / 37,500             $0/$0
  @ $.50       0           $0         175,000 / 0                  $0/$0
  @ $.75       0           $0          20,000 / 0                  $0/$0


(1)   Represents  the total gain which  would be  realized  if all  in-the-money
      options held on that date were  exercised,  determined by multiplying  the
      number of shares underlying the options by the difference  between the per
      share  option  exercise  price and the  market  price of the  shares.  The
      exercise price of all options held by the Named Executives was higher than
      the December 31, 2003 market price of $.13 of the  Corporation's  publicly
      traded Common Stock, resulting in no value.



                            COMPENSATION OF DIRECTORS

Directors of the  Corporation  do not receive fees for their  services,  but are
eligible  to  receive  stock  option  grants  and  restricted  shares,  and  are
reimbursed  for  expenses  related to their  activities  as  directors.  When an
individual  ceases to be a director of the  Corporation,  he loses the rights to
any shares under option which have not vested as of that date.


                                 CODE OF ETHICS

Recently  enacted Item 406 of Regulation S-B of the  Securities  Exchange Act of
1934 requires disclosure of whether the Corporation has adopted a code of ethics
that applies to its principal  executive officer,  principal  financial officer,
principal  accounting  officer  or  controller,  or persons  performing  similar
functions,  and to explain why if it has not adopted such a code of ethics.  For
purposes of Item 406, the term "code of ethics" refers to written standards that
are  reasonably  designed  to (1) deter  wrongdoing  and to  promote  honest and
ethical conduct,  including the ethical handling of actual or apparent conflicts
of interest between personal and  professional  relationships;  (2) ensure full,
fair,  accurate,  timely,  and  understandable  disclosure  in  public  reports,
documents and communications; (3) ensure compliance with applicable governmental
laws,  rules and  regulations;  (4)  ensure  the prompt  internal  reporting  of
violations  of the code to an  appropriate  person or persons  identified in the
code; and (5) provide accountability for adherence to the code.

Adoption of a written code of ethics requires the expenditure of time and funds.
The  Corporation  has not adopted such a written code of ethics due to its small
size and limited financial resources.  The Board of Directors intends to adopt a
code of ethics for the relevant  officers of the  Corporation as soon as funding
and staffing permit.


                             INDEPENDENT ACCOUNTANTS

The  Corporation  has  had  no  disagreements   with  its  current   independent
accountants,  Hausser + Taylor LLC, on any matter of  accounting  principles  or
practices or financial statement  disclosure.  Hausser + Taylor LLC has been the
Corporation's  independent  accountants  since December 17, 2002. It is expected
that a  representative  of  Hausser + Taylor  LLP will be  present at the Annual
Meeting and will have an opportunity to make a statement,  should they desire to
do so, and will be available to answer appropriate questions.


                          ANNUAL REPORT ON FORM 10-KSB

A copy  of the  Corporation's  2003  Annual  Report  on Form  10-KSB  containing
financial statements of the Corporation, but excluding exhibits, has been mailed
to all shareholders with this Notice of Meeting and Proxy Statement. Exhibits to
the Form 10-KSB are available from the Corporation upon request and payment of a
reasonable fee solely for  reimbursement of expenses in furnishing the requested
exhibits(s).  The entire Form 10-KSB,  including  exhibits,  is available at the
SEC's website  http://www.sec.gov  and via a link from the Corporation's website
http://www.sonexresearch.com.


                             COMMON STOCK DIRECTOR

                                                        Year first
                                                        elected to     Year term
            Name                     Age      Class      the Board      expires
   ----------------------            ---      -----      ---------      -------

   Andrew A. Pouring (nominee)        72       III          1980          2004

Dr.  Andrew  A.  Pouring  has been a  full-time  employee,  director,  and Chief
Scientist of the  Corporation  since 1980,  serving as President from April 1980
through  November  1991,  and as Chief  Executive  Officer from May 1985 to July
2004,  at which  time he was named  Chairman  of the  Board and Chief  Technical
Officer.  In October 2004 he was named President and Chief Executive Officer. In
November 1991 he was elected a Vice  Chairman of the Board of Directors.  He has
co-authored  all of the  Corporation's  patented  inventions.  Prior to  forming
Sonex,  Dr. Pouring  served as a Professor of Aerospace  Engineering at the U.S.
Naval Academy,  including four years as the Chairman of the Academy's Department
of Aerospace  Engineering.  Dr. Pouring is a member of various  professional and
scientific societies, including the American Society of Mechanical Engineers and
the Society of  Automotive  Engineers.  Dr.  Pouring  received his Bachelors and
Masters degrees in mechanical engineering from Rensselaer Polytechnic Institute.
He received his Doctor of Engineering degree from Yale University, where he also
was a post doctoral research fellow and lecturer.


                          PREFERRED STOCK DIRECTOR

                                                        Year first
                                                        elected to     Year term
            Name                     Age      Class      the Board      expires
   ----------------------            ---      -----      ---------      -------

   George E. Ponticas (nominee)       45        I           2004          2004


Mr. George E. Ponticas has served as Vice President of Finance,  Chief Financial
Officer,  Secretary and Treasurer of the Corporation from September 1991 to June
2004 and from August 2004 to the present.  From May 1987 through August 1991, he
served as the Company's Controller and Assistant Secretary.  Mr. Ponticas served
as a director of the Corporation during February and March 2004 and rejoined the
board in November 2004. Prior to joining Sonex, Mr. Ponticas was a member of the
auditing  staff  of Price  Waterhouse  in  Baltimore,  Maryland,  attaining  the
position of audit manager. Mr. Ponticas is a Certified Public Accountant, and is
a member of the  American  Institute  of Certified  Public  Accountants  and the
Maryland  Association of Certified Public  Accountants.  He received his B.S. in
Accounting from Loyola College in Maryland.


                     OTHERS SERVING AS DIRECTORS DURING 2004

Mr. Lawrence H. Hyde served as a director of the Corporation from September 1986
until  February  2004,  serving as  Chairman of the Board from June 1987 to June
1993 and as President  from October 1997 through  September  2001. Mr. Hyde is a
private  investor  with  interests  in a number of publicly and  privately  held
companies.  He spent the majority of his business  career as an executive in the
automotive industry, serving in various engineering,  marketing,  international,
and  chief  executive  capacities  for  AM  General  Company,   American  Motors
Corporation  and Ford Motor Co. Mr.  Hyde is a graduate  of Harvard  College and
Harvard Business School.

Mr. Charles C. McGettigan  served as a director of the Corporation from February
2002 until  January  2004.  He was a  founding  partner in 1991 and is a general
partner of Proactive Investment Managers,  L.P., which is the general partner of
Proactive Partners,  L.P. In 1988 Mr. McGettigan co-founded  McGettigan,  Wick &
Co., Inc., an investment  banking firm,  following a career as an executive with
major investment  banking firms,  including  Hambrecht & Quist, Inc. and Dillon,
Read & Co. Inc.  Mr.  McGettigan  is a graduate of  Georgetown  University,  and
received  his MBA in  Finance  from The  Wharton  School  of the  University  of
Pennsylvania.

Mr.  Herbert J.  Mitschele,  Jr. served as a director of the  Corporation  on an
interim basis in February and March 2004.  Mr.  Mitschele is a retired  business
owner who has been a shareholder of the Company for approximately  twenty years.
He received his B.S. in Business and Administration from Fordham University.

Mr. Roger D. Posey joined the  Corporation  as President in February  2004,  was
named a director in March 2004,  and was named Chief  Executive  Officer in July
2004.  In  October  2004 Mr.  Posey  resigned  as Chief  Executive  Officer  and
President,  and in November 2004 he resigned from the Board of Directors.  Prior
to joining Sonex, Mr. Posey held management and operational leadership positions
with CSX Transportation, Inc., Noise Cancellation Technologies Inc., and Tenneco
Automotive  Inc.,  and  personally  directed a successful  turnaround of a large
privately  held  metals  manufacturing  company.  He is a member  of a number of
professional  organizations,   including  the  Acoustical  Society  of  America,
Institute of Noise Control Engineers,  American Industrial Hygiene  Association,
among others;  further, he has written and published several technical articles,
presented  within the U.S.  and  throughout  the World.  Mr.  Posey holds a B.S.
degree in Science Education from the University of Maryland.

Mr. Myron A. ("Mike") Wick, III,  served as a director of the  Corporation  from
November 1991 until January 2004, and as Chairman of the Board of Directors from
June 1993 until October 2002. He was a founding partner in 1991 and is a general
partner of Proactive Investment Managers,  L.P., which is the general partner of
Proactive  Partners,  L.P. In 1988 Mr. Wick co-founded  McGettigan,  Wick & Co.,
Inc., an  investment  banking  firm.  Mr. Wick received a B.A.  degree from Yale
University and an MBA from the Harvard Business School.

Mr. Jim Z.I.  Williams served as a director of the  Corporation  from April 2004
until November 2004. Mr. Williams is the President and Chief  Executive  Officer
of E. I.  Williams  Steel  Division of Ajax  Ontario,  Canada,  a company  which
manufactures  quality  low  cost - high  value  noise  control  and  suppression
equipment.  He has twenty years of management leadership  experience,  serves on
the Board of  Directors  of a number of  companies,  and is  involved  with many
charitable activities. Mr. Williams holds a B.S. degree in the Sciences from the
University of Toronto.



          COMMON STOCK PROPOSAL - ELECTION OF COMMON STOCK DIRECTOR

The Board of Directors  has  nominated Dr. Andrew A. Pouring for election by the
shareholders to serve as a Class III Common Stock director until the 2007 Annual
Meeting  of  Shareholders.  The  persons  named in the  enclosed  Proxy have the
intention  of voting  each  properly  submitted  Proxy for the  election  of the
nominee unless the shareholder indicates the vote should be withheld. If elected
by the shareholders,  Dr. Pouring will serve until his successor is duly elected
and  qualified.  Although the Board of Directors does not  contemplate  that the
nominee will be unable to serve, if such a situation  arises prior to the Annual
Meeting,  the persons named in the Proxy will vote in accordance with their best
judgment  for such  person  or  persons  as may be  designated  by the  Board of
Directors, unless the shareholder has directed otherwise.

The Board of Directors recommends that the shareholders vote FOR the election of
Andrew A. Pouring as a Class III Common Stock director.


        PREFERRED STOCK PROPOSAL - ELECTION OF PREFERRED STOCK DIRECTOR

The term as director of Mr.  George E.  Ponticas  will expire at the next (2004)
Annual Meeting of Shareholders  because he was elected by the Board of Directors
to fill a vacancy  rather than by the  shareholders  at an annual  meeting.  The
Board of Directors has nominated Mr.  Ponticas for election by the  shareholders
to serve as a Class I Preferred  Stock director until the 2005 Annual Meeting of
Shareholders.  The persons  named in the  enclosed  Proxy have the  intention of
voting each properly  submitted Proxy for the election of the nominee unless the
shareholder   indicates  the  vote  should  be  withheld.   If  elected  by  the
shareholders,  Mr.  Ponticas  will serve until his successor is duly elected and
qualified. Although the Board of Directors does not contemplate that the nominee
will be unable to serve, if such a situation arises prior to the Annual Meeting,
the persons named in the Proxy will vote in accordance  with their best judgment
for such  person or  persons  as may be  designated  by the Board of  Directors,
unless the shareholder has directed otherwise.

The Board of Directors recommends that the shareholders vote FOR the election of
George E. Ponticas as a Class I Preferred Stock director.


             SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities  Exchange Act of 1934 requires the Corporation's
officers  and  directors,  and persons who  beneficially  own more than 10% of a
registered class of the Corporation's  equity  securities,  to file with the SEC
initial  reports of  beneficial  ownership  on Form 3 and  reports of changes in
beneficial ownership on Form 4, and to provide copies of all such reports to the
Corporation.

Based  solely on its review of the  copies of such  reports  received  by it, or
written  representations  from  certain  reporting  persons that no reports were
required for those persons,  the Corporation  believes that all of its officers,
directors,  and  greater  than 10%  shareholders  complied  with all such filing
requirements  related to  beneficial  ownership of Common Stock during 2003 with
the following exceptions:  Dr. Andrew A. Pouring and Mr. George E. Ponticas, the
Corporation's Chief Executive and Chief Financial Officers, respectively, failed
to file timely Form 4s to report the  December 31, 2003 grant to each of them of
ten-year  options  vesting 25% per year to purchase  100,000 and 50,000  shares,
respectively,  of Common  Stock at an  exercise  price of $.25 per share,  which
exercise price was higher than the December 31, 2003 market price of $.13 of the
Company's  publicly traded Common Stock. Both Dr. Pouring and Mr. Ponticas filed
the required Form 4s in May 2004.


                                  OTHER MATTERS

The Board of  Directors  does not know of any  matters  to be  presented  at the
Annual Meeting other than those specifically set forth in this Notice of Meeting
and Proxy  Statement.  If any such matters should arise, it is intended that the
persons  named  in and  acting  under  the  enclosed  form  of  Proxy  or  their
substitutes will vote thereon in accordance with their best judgment.


                              SHAREHOLDER PROPOSALS

Any  shareholder  proposal  intended to be included in the  Corporation's  proxy
statement  and form of proxy for  presentation  at the next  annual  shareholder
meeting  must comply with  certain  rules and  regulations  with  respect to the
number and length of  proposals,  eligibility  of persons  entitled to have such
proposals  included,  and other aspects.  Interested persons should refer to the
Securities  Exchange  Act of 1934 and  other  applicable  laws and  regulations.
Proposals intended to be included in the Corporation's  proxy statement and form
of proxy for  presentation  at the 2005 Annual Meeting of  Shareholders  must be
received at the Corporation's principal executive offices in Annapolis, Maryland
at least 120 days  before  the  anniversary  date of  mailing  of the 2004 proxy
materials.  Based on the date of mailing of the 2004 proxy  materials,  the date
for receipt of  proposals  intended to be  included in the  Corporation's  proxy
statement  and form of proxy for  presentation  at the 2005  Annual  Meeting  of
Shareholders  is August 3, 2005.  It is likely,  however,  that the 2005  Annual
Meeting of Shareholders will be held earlier in the year than is the 2004 Annual
Meeting of Shareholders. Persons intending to present proposals for inclusion in
the Corporation's proxy statement and form of proxy for presentation at the 2005
Annual  Meeting of  Shareholders  are urged to contact the  Corporation  well in
advance of August 3, 2005.





                   APPENDIX A - FORM OF PROXY - COMMON STOCK



PROXY                  Sonex Research, Inc. - Common Stock


           THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS


The  undersigned  hereby  appoints GEORGE E. PONTICAS as Proxy with the power to
appoint his substitute,  to represent and vote all shares of Common Stock of and
on behalf of the  undersigned  upon or in connection with the transaction of all
other  business  at the  Annual  Meeting  of  Holders  of Common  Stock of Sonex
Research,  Inc.  ("Sonex") to be held  December 20, 2004,  and any  adjournments
thereof, with all powers the undersigned would possess if personally present and
voting at such meeting.


    The Board of Directors unanimously recommends a vote "FOR" the following:


COMMON STOCK PROPOSAL 1:  Election of Directors

        Andrew A. Pouring          [ ] FOR             [ ] WITHHOLD AUTHORITY


WHEN  PROPERLY  EXECUTED  AND  RETURNED  THIS  PROXY WILL BE VOTED IN THE MANNER
DIRECTED  HEREIN BY THE UNDERSIGNED  SHAREHOLDER.  IF NO DIRECTION IS INDICATED,
THIS  PROXY WILL BE VOTED  "FOR"  COMMON  STOCK  PROPOSAL 1 AS SET FORTH ON THIS
CARD.


                                     Dated _______________ , 2004


                                     ----------------------------
                                              Signature

                                     ----------------------------
                                      Signature (if held jointly)


PLEASE SIGN EXACTLY AS NAME(S) APPEAR(S) HEREON. If shares are held in the names
of two or more  persons,  all must sign.  When  signing in a  representative  or
fiduciary  capacity,  give full title as such. If signer is a corporation,  sign
corporate name by fully authorized officer.



                APPENDIX B - FORM OF PROXY - PREFERRED STOCK



PROXY              Sonex Research, Inc. - Preferred Stock


           THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS


The  undersigned  hereby  appoints  ANDREW A. POURING as Proxy with the power to
appoint his  substitute,  to represent and vote all shares of Preferred Stock of
and on behalf of the  undersigned,  as designated below at the Annual Meeting of
Shareholders  of Sonex  Research,  Inc. to be held  December 20,  2004,  and any
adjournments   thereof,  with  all  powers  the  undersigned  would  possess  if
personally present and voting at such meeting.


    The Board of Directors unanimously recommends a vote "FOR" the following:


PREFERRED STOCK PROPOSAL 1:  Election of Class I Director

        George E. Ponticas         [ ] FOR             [ ] WITHHOLD AUTHORITY


WHEN  PROPERLY  EXECUTED  AND  RETURNED  THIS  PROXY WILL BE VOTED IN THE MANNER
DIRECTED  HEREIN BY THE UNDERSIGNED  SHAREHOLDER.  IF NO DIRECTION IS INDICATED,
THIS  PROXY WILL BE VOTED  "FOR"  COMMON  STOCK  PROPOSAL 1 AS SET FORTH ON THIS
CARD.


                                     Dated _______________ , 2004


                                     ----------------------------
                                              Signature

                                     ----------------------------
                                      Signature (if held jointly)


PLEASE SIGN EXACTLY AS NAME(S) APPEAR(S) HEREON. If shares are held in the names
of two or more  persons,  all must sign.  When  signing in a  representative  or
fiduciary  capacity,  give full title as such. If signer is a corporation,  sign
corporate name by fully authorized officer.